bevacizumab,atezolizumab
roche
['imbrave050', 'hcc', 'atezo']
the #oncoalerttoptweet day 3 #aacr23 tweet by imbrave050 fantastic news for for hcc. adjuvant atezo/bev met its primary end point of recurrence free survival. will there be a new standard of care after liver cancer resection? can't wait for final 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨